Bladder cancer: open trials in Argentina

9 open trials have a site in Argentina. Registry data; only the trial team decides who can take part.

NCT06319820
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Hospital Sirio Libanes, Buenos Aires · Investigaciones Clinico Moleculares (ICM), Chabas · Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica, Córdoba · Centro Urológico Profesor Bengió, Córdoba · Hospital Privado de la Comunidad, Mar del Plata · Sanatorio de la Mujer, Rosario
Registry updated 2026-11-03
NCT06919965
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Investigaciones Clinico Moleculares (ICM), Chabas · Instituto Alexander Fleming, Ciudad Evita · Centro Urológico Profesor Bengió, Córdoba · Sanatorio de la Mujer, Rosario · Hospital Sirio Libanes, San Martín de los Andes
Registry updated 2026-11-03
NCT07419295
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Hospital Italiano de Buenos Aires ( Site 0004), Ciudad Autonoma de Buenos Aires · Asociacion de Beneficencia Hospital Sirio Libanes ( Site 0003), Ciudad Autonoma de Buenos Aires · Instituto Alexander Fleming ( Site 0002), Ciudad Autónoma de Buenos Aires · Instituto de Oncologia de Rosario ( Site 0005), Rosario
Registry updated 2026-11-03
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Hospital Alemán, Buenos Aires · DIABAID, Buenos Aires · Hospital Sirio Libanes, Caba · Centro Médico Austral, Ciudad Autonoma Buenos Aires · Centro de Investigaciones Medicas y Desarrollo LC SRL (LC Investigacion), Ciudad Autonoma Buenos Aires · Centro de Investigaciones Medicas Mar Del Plata, Mar del Plata
Registry updated 2026-10-26
NCT06833073
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Asociación de Beneficencia Hospital Sirio Libanés ( Site 0303), Buenos Aires · Hospital Italiano de Buenos Aires ( Site 0307), CABA · Instituto Alexander Fleming ( Site 0306), Ciudad Autónoma de Buenos Aires · Fundación CORI para la Investigación y Prevención del Cáncer ( Site 0301), La Rioja · Instituto de Investigaciones Clinicas Mar de Plata ( Site 0305), Mar del Plata · Fundacion Estudios Clinicos ( Site 0304), Rosario · Sanatorio Parque ( Site 0300), Rosario
Registry updated 2026-10-01
NCT05951179
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Trial Treatment · Phase 2 · Protara Therapeutics
Hospital Britanico de Buenos Aires, Buenos Aires · Hospital Italiano de Buenos Aires (HIBA), Buenos Aires · Hospital Sirio Libanes, Caba · Centro Argentino de Urologia, CABA · CEMAIC, Córdoba · Centro Urologico Profesor Bengio SA, Córdoba · Clinica Privada Independencia, Munro
Registry updated 2026-08-24
NCT07106762
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Hospital Italiano de Buenos Aires, ABB · Hospital Británico de Buenos Aires, CABA · Instituto Alexander Fleming, CABA · Asociación de Beneficencia Hospital Sirio Libanés, Ciudad Autonoma de Buenos Aires · IONC Instituto Oncologico de Cordoba Fundacion Richardet Longo, Córdoba · Fundacion Centro Oncologico de Integracion Regional, Mendoza
Registry updated 2026-07-29
NCT04879329
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Trial Treatment · Phase 2 · Seagen, a wholly owned subsidiary of Pfizer
Hospital Alemán, Buenos Aires · Hospital Sirio Libanes - Buenos Aires, Buenos Aires · Centro de Investigaciones Médicas y Desarrollo LC S.R.L, Buenos Aires · Instituto Medico Especializado Alexander Fleming, Buenos Aires · Centro Oncologico Korben, CABA · Centro Medico Austral, CABA · Instituto Oncológico de Córdoba, Córdoba · Clínica Viedma, Viedma
Registry updated 2026-07-22
NCT06972615
Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy
Trial Treatment · Phase 2 · BLATAM
BLATAM, CABA
Registry updated 2026-05-28

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error